SOC
Surgery on Children

Surgery on Children Journal aims to publish issues related to Pediatric Surgery, Pediatric Neurosurgery, Pediatric Plastic Surgery, Pediatric Cardiovascular Surgery, Pediatric Orthopedic Surgery, Pediatric Vascular Surgery, Pediatric Gynecology and Obstetrics, Pediatric Ear Nose Throat, Ophthalmology, Pediatric Anesthesiology and Reanimation, Pediatric Urology, Pediatric Surgical Intensive Care Clinic, and other clinical surgery fields on children of the highest scientific and clinical value at an international level and accepts articles on these topics.

eISSN: 3023-7289
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
Nuclear medicine approaches in the field of oncologic pediatric surgery and review the risk factors for pediatric thyroid nodules
Abstract
Imaging methods used in nuclear medicine are non-invasive and can be applied to all pediatric age groups, including the neonatal period. F-18 FDG-PET/CT is used for staging, evaluation of treatment response, detection of metastases, and follow-up of various pediatric malignancies. In addition, the incidence of thyroid cancer in childhood has recently increased. In this review, we examined the F-18 FDG PET/CT imaging method that guide the management of the most common malignancies in children. We also discuss in detail the risk factors used in the diagnosis of thyroid cancer frequently encountered by pediatric surgeons.

Keywords : Pediatric surgery, nuclear medicine, PET/CT, thyroid cancer, risk factors

Download Article


1. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet. 2004;364(9451):2097-2105.
2. Türkiye Halk Sağlığı Kanser Daire Başkanlığı http://hsgm.saglik.gov.tr Avalible at. Accessed Ankara 2022.
3. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457-1467.
4. Bıçakçı N, Elli M.18Fluorine-fluorodeoxyglucose PET/CT ımaging in childhood malignancies. Mol Imaging Radionucl Ther. 2021;30(1):18-27.
5. Society of nuclear medicine guidelines. Avaliable at: http://snmmi.files.cms-plus.com/docs/Pediatric_dose_guidelines_JNM_2011_52_318_1382732155632_11.pdf. Accessed 23.03.2015
6. Jhanwar YS, Straus DJ. The role of PET in lymphoma. J Nucl Med. 2006; 47(8):1326-1334.
7. Cheng G, Servaes S, Zhuang H. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma. Leuk Lymphoma. 2013;54(4):737-742.
8. Chawla M, Kumar R, Agarwala S, Bakhshi S, Gupta DK, Malhotra A. Role of positron emission tomography in staging and early chemotheraphy in staging and early chemotheraphy responce evaluation in children with neuroblastoma. Indian J Nucl Med. 2010;25(4):147-155.
9. Du L, Liu L, Zhang C, et al. Role of surgery in the treatment of patients with high risk neuroblastoma who have poor response to induction chemotherapy. J Pediatr Surg. 2014;49(4):528-533.
10. Alexander N, Vali R, Ahmadzadehfar H, Shammas A, Baruchel S. Review: the role of radiolabeled DOTA-conjugated peptides for ımaging and treatment of childhood neuroblastoma. Curr Radiopharm. 2018;11(1):14-21.
11. Smith MA, Seibel NL, Altekruse SF, et al. Outcomes for children and adoles- cents with cancer: challenges for the twenty-first century. J Clin Oncol. 2010;28(15):2625-2634.
12. Moinul Hossain AK, Shulkin BL, Gelfand MJ, et al. FDG positron emission tomography/computed tomography studies of Wilms’ tumor. Eur J Nucl Med Mol Imaging. 2010;37(7):1300-1308.
13. Begent J, Sebire NJ, Levitt G, et al. Pilot study of F (18)-fluorodeoxyglucose positron emission tomography/computerised tomography in Wilms’ tumour: correlation with conventional imaging, pathology and immunohistochemistry. Eur J Cancer. 2011;47(3):389-396.
14. Misch D, Steffen IG, Schönberger S, et al. Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour. Eur J Nucl Med Mol Imaging. 2008;35(9):1642-1650.
15. Misch D, Steffen IG, Schönberger S, et al. Use of positron emission tomography for staging, preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour. Eur J Nucl Med Mol Imaging. 2008;35(9):1642-1650.
16. Weiner E. Soft tissue sarcoma, in Carachi R, Azmy A, Grosfeld JL (eds): The Surgery of Childhood Tumors, Oxford University Press, 2009.
17. Mollen KP, Rodeberg DA. Diagnosis and treatment of rhabdomyosarcoma. In Coran AG, Adzick NS, Krum- mel TM, et al. (eds): Pediatric Surgery, Philadelphia, Mosby, 2012.
18. Federico SM, Spunt SL, Krasin MJ, et al. Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma. Pediatr Blood Cancer. 2013;60(7):1128-1134. doi:10.1002/pbc.24430
19. Tateishi U, Hosono A, Makimoto A, et al. Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma. Ann Nucl Med. 2009;23(2):155-161.
20. Volker T, Denecke T, Steffen I, et al. Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol. 2007;25(34):5435-5441.
21. Ricard F, Cimarelli S, Deshayes E, Mognetti T, Thiesse P, Giammarile F. Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma. Clin Nucl Med. 2011;36(8):672-677.
22. Vergamini LB,Frazier AL,Abrantes FL,Ribeiro KB,Rodriguez-Galindo C.Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population based study.J Pediatr.2014;164(6):1481-1485.
23. Guille JT,Opoku-Boateng A,Thibeault SL,Chen H.Evaluation and management of the pediatric thyroid nodule.Oncologist.2015;20(1):19-27.
24. Buryk MA, Simons JP, Picarsic J, et al. Can malignant thyroid nodules be distinguished from benign thyroid nodules by clinical characteristics? A review of 89 pediatric patients with thyroid nodules.Thyroid.2015;25(4):392-400.
25. Grant EG, Tessler FN, Hoang JK, et al. Thyroid ultrasound reporting lexicon: white paper of the ACR thyroid imaging, reporting and data system (TIRADS) committee. J Am Coll Radiol. 2015;12(12 Pt A):1272-1279.
26. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol. 2009;132(5):658-665.
27. Gupta A,Ly S,Castroneves LA, et al.A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.J Clin Endocrinol Metab.2013;98(8):3238-3245.
28. Penta L, Cofini M, Lanciotti L, Leonardi A, Principi N, Esposito S. Hashimoto’s disease and thyroid cancer in children: are they associated?Front.Endocrinol.2018;9:565.
29. Zimmermann MB, Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies.Thyroid Res.2015;8(1):8.
30. Bogovic CT, Ilic TM, Girotto N, Grbac IS. Risk factors for thyroid cancer: what do we know so far? Acta Clin Croat. 2020;59(Suppl 1):66-72.
31. Karapanou O, Tzanela M, Vlassopoulou B, Kanaka GC. Differentiated thyroid cancer in childhood: a literature update. Hormones (Athens). 2017; 16(4):381-387.
32. Zhang B, Wu W, Shang X, Huang D, Liu M, Zong L. Incidence and prognosis of thyroid cancer in children: based on the SEER database. Pediatr Surg Int. 2022;38(3):445-456.
33. Paulson VA, Rudzinski ER, Hawkins DS. Thyroid cancer in the pediatric population. Genes (Basel). 2019;10(9):723.
34. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156(1):167-172.
35. Jannin A, Escande A, Al Ghuzlan A, et al. Anaplastic thyroid carcinoma: an update. Cancers (Basel). 2022;14(4):1061.
36. Balachandar S, La Quaglia M, Tuttle RM, Heller G, Ghossein RA, Sklar CA. Pediatric differentiated thyroid carcinoma of follicular cell origin: prognostic significance of histologic subtypes. Thyroid. 2016;26(2):219-226.
37. Agrawal N, Akbani R, Aksoy BA, et al. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159(3):676-690.
38. Pekova B, Sykorova V, Dvorakova S, et al. RET, NTRK, ALK, BRAF, and MET fusions in a large cohort of pediatric papillary thyroid carcinomas. Thyroid. 2020;30(12):1771-1780.
39. Monaco SE,Pantanowitz L,Khalbuss WE, et al.Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration. Cancer Cytopathol.2012;120(5):342-350.
40. Ricarte-Filho JC, Li S, Garcia-Rendueles MER, et al. Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers. J Clin Invest. 2013;123(11):4935-4944.
41. Yamashita S, Saenko V. Mechanisms of disease: molecular genetics of childhood thyroid cancers. Nat Rev Endocrinol. 2007;3(5):422-429.
42. Franco AT, Ricarte-Filho JC, Isaza A, et al. Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers. J Clin Oncol. 2022;40(10):1081-1090.
43. Landa I, Ibrahimpasic T, Boucai L, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052-1066.
44. Isgor A, Uludag M, Aygun N. Handbook of thyroid parathyroid adrenal. 1st ed. Istanbul: BAU Publications; 2023.
45. Tessler FN, Middleton WD, Grant EG, et al. ACR thyroid ımaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol. 2017;14(5):587-595.
46. Horvath E, Majlis S, Rossi R, et al. An ultrasonogram reporting system for thyroid nodules stratifying cancer risk for clinical management.J Clin Endocrinol Metab. 2009;94(5):1748-1751.
47. Francis GL, Waguespack SG, Bauer AJ, et al. American thyroid association guidelines task force. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716-759.
48. McHenry CR, Huh ES, Machekano RN.Is nodule size an independent predictor of thyroid malignancy?Surgery.2008;144(6):1062-1069.
49. Leboulleux S, Girard E, Rose M, et al. Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.J Clin Endocrinol Metab.2007;92(9):3590-3594.
50. Ahmad H, al-Hadidi A, Bobbey A, et al. Pediatric adaptions are needed to improve the diagnostic accuracy of thyroid ultrasound using TI-RADS. J Pediatr Surg. 2021;56(6):1120-1125.
51. Strickland KC, Howitt BE, Barletta JA, et al. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): a retrospective analysis of atypical and suspicious nodules. Cancer Cytopathol.2018;126(2):86-93.
52. Rossi ED, Mehrotra S, Kilic AI, et al. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group. Cancer Cytopathol. 2018;126(1):27-35.
53. Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid.2023;33(9):1039-1044.
54. Cherella CE, Angell TE, Richman DM, et al. Differences in thyroid nodule cytology and malignancy risk between children and adults. Thyroid. 2019; 29(8):1097-1104.
55. Lebbink CA, Links TP, Czarniecka A, et al. European thyroid association guidelines for the management of pediatric thyroiesponse and radioiodine uptaka. Eur Thyroid J. 2022;11(6):e220146.
56. Han M, Fan F. Bethesda system for reporting thyroid cytopathology an updated review. J Clin Transl Pathol. 2023;3(2):84-98.
57. Patel J, Klopper J, Cottrill EE. Molecular diagnostics in the evaluation of thyroid nodules: current use and prospective opportunities. Front Endocrinol (Lausanne).2023;14:1101410.
58. Xing M. Genetic-guided risk assessment and management of thyroid cancer. Endocrinol Metab Clin North Am. 2019;48(1):109-124.
Article available in :
Volume 2, Issue 1, 2025
Page : 21-27
https://doi.org/10.51271/SOC-0029
Article Information
Received : 02 Haz 2024
Accepted : 15 Tem 2024
Published : 20 Oca 2025
Corresponding Author :

Nilüfer Bıçakcı: Department of Nuclear Medicine, Samsun Training and Research Hospital, Samsun, Turkiye

[email protected]
Citation : Bıçakcı N, Silov G, Bıçakcı Ü, Batı F, Kırtıloğlu B. Nuclear medicine approaches in the field of oncologic pediatric surgery and review the risk factors for pediatric thyroid nodules. Surg Child. 2025;2(1):21-27.

Read: 225
Download : 701
Cited: 1
_Footer